Baxter Q3 2021 Earnings Report
Key Takeaways
Baxter's Q3 2021 results showed a 9% increase in worldwide sales, reaching $3.2 billion. U.S. GAAP earnings per share increased by 29% to $0.89, and adjusted EPS increased by 23% to $1.02. The company has updated its full-year outlook, expecting sales growth of 7% to 8% and U.S. GAAP EPS of $2.82 to $2.86.
Third-quarter revenue increased 9% on a reported basis, reaching $3.2 billion.
U.S. GAAP earnings per share (EPS) increased 29% to $0.89; Adjusted EPS increased 23% to $1.02.
Baxter expects full-year 2021 sales growth of 7% to 8% on a reported basis.
Baxter now expects full-year U.S. GAAP EPS of $2.82 to $2.86 and adjusted EPS of $3.58 to $3.62.
Baxter
Baxter
Baxter Revenue by Geographic Location
Forward Guidance
For full-year 2021, Baxter now expects U.S. GAAP earnings of $2.82 to $2.86 per diluted share and adjusted earnings, before special items, of $3.58 to $3.62 per diluted share. The company expects sales growth of 7% to 8% on a reported basis, 5% to 6% on a constant currency basis and 4% to 5% on an operational basis.
Positive Outlook
- Sales growth of 3% to 4% on a reported basis
- Sales growth of 4% to 5% on a constant currency basis
- Sales growth of 3% to 4% on an operational basis
- U.S. GAAP earnings of $0.75 to $0.79 per diluted share
- Adjusted earnings, before special items, of $1.00 to $1.04 per diluted share
Revenue & Expenses
Visualization of income flow from segment revenue to net income